pharm exam 4 medication Flashcards
Glucagon injectable
MOA:
indication:
SE:
NI/CE:
CI:
Types of insulin (Insulin name/class, onset/peak/duration, administration
considerations, adverse effects)
MOA:
indication:
SE:
NI/CE:
CI:
Glipizide oral (Class: Sulfonylurea)
MOA:
indication:
SE:
NI/CE:
CI:
Metformin oral (Class: Biguanide)
MOA:
indication:
SE:
NI/CE:
CI:
Sitagliptin (Januvia) oral (Class: DPP4 inhibitor)
MOA:
indication:
SE:
NI/CE:
CI:
Empagliflozin (Jardiance) oral (Class: SGLT2 inhibitor)
MOA:
indication:
SE:
NI/CE:
CI:
Semaglutide (Wygovy) injectable (Class: GLP-1 agonists)
MOA:
indication:
SE:
NI/CE:
CI:
Prednisone
MOA:
indication:
SE:
NI/CE:
CI:
Methylprednisolone (IV)
MOA:
indication:
SE:
NI/CE:
CI:
Fludrocortisone
MOA:
indication:
SE:
NI/CE:
CI:
Levothyroxine
MOA:
indication:
SE:
NI/CE:
CI:
Propylthiouracil (PTU)
MOA:
indication:
SE:
NI/CE:
CI:
Calcitonin
MOA:
indication:
SE:
NI/CE:
CI:
Alendronate
end of endo
MOA:
indication:
SE:
NI/CE:
CI:
Antacids - calcium carbonate (Tums)
MOA: Neutralize stomach acid and elevate pH
indication: Symptomatic relief of heartburn, acid indigestion and upset stomach
SE: Constipation, Hypercalcemia, Rebound acidity when stopped
NI/CE: come in tables, chewable, capsules and liquid, It can be taken three to four times a day, Do not administer within 1-2 hours or other medications, Drink a full glass of water after administration
CI: Kidney disease, GI obstruction
Histamine-2 (H2) receptor antagonist - Famotidine
MOA: Block histamine-2 receptor sites of parietal cell which reduces hydrochloric acid
indication: Heartburn, GERD, Peptic ulcer disease, erosive esophagitis, Adjunct treatment for upper GI bleeding
SE: Constipation or diarrhea, CNS effects (headaches or dizziness)
NI/CE: Available over the counter, but given IV in the hospital setting, Take 15-60 minutes before eating or
drinking
CI:
PPI – pantoprazole
MOA: Blocks the secretion of hydrochloric
acid at the proton pump
indication: GERD, erosive esophagitis, Prophylactic with surgery, In combination with antibiotics for H.Pylori infection, Short-term treatment of active
duodenal ulcers
SE: Headache, Abdominal pain, diarrhea or constipation, Acute renal dysfunction, Long-term: Osteoporosis & bone fracture, Potential zinc, magnesium, or B12 deficiency, Immediately report signs of bleeding ulcers such as coughing/vomiting of blood
NI/CE: Available orally, with an NG tube, or as IV injection in the hospital setting, Can be taken with or without food
CI:
Mucosal protectants - Sucralfate
MOA: Locally covers the ulcer site and protects the sites against acid, pepsin, and bile salts
indication: Promote ulcer healing
SE: constipation
NI/CE: Administer on an empty stomach, 2 hours after or 1 hour before meal
CI: Renal failure or dialysis